Inhibitor (IK) of IFN-γ induced HLA class II antigens expression also inhibits HLA class II constitutive expression in the human Raji B cell line

Oncogene

Volumn 14, Issue 12, 1997, Pages 1453-1461

  Vedrenne, Jocelyn ^a   Assier, Eric ^a   Pereno, Raffaele ^a   Bouzinba Segard, Haniaa ^a   Azzarone, Bruno ^b   Jasmin, Claude ^b   Charron, Dominique ^a   Krief, Patricia ^a  

^a INSERM   (France)

^b HÔPITAL PAUL BROUSSE   (France)

Author keywords

CIITA; IFN ; IK; MHC class II

Indexed keywords

GAMMA INTERFERON; HLA ANTIGEN CLASS 2; MESSENGER RNA; REPRESSOR PROTEIN; TRANSACTIVATOR PROTEIN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DNA TRANSFECTION; GENE REPRESSION; HISTOCOMPATIBILITY GENE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RAJI CELL; TRANSCRIPTION REGULATION;

EID: 0030894312     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1200971     Document Type: Article

References (26)

1. Accolla RS. (1983). J. Exp. Med., 157, 1053-1058.
2. Bénichou B and Strominger JL. (1991). Proc. Natl. Acad. Sci. USA, 88, 4285-4288.
3. Benoist C and Mathis D. (1990). Annu. Rev. Immunol., 8, 681-715.
4. Brown JA, He XF, Westerheide SD and Boss JM. (1995). Immunogenetics, 43, 88-91.
5. Chomczynski P and Sacchi N. (1987). Analytical Biochemistry, 162, 156-159.
6. de Preval C, Hadam MR and Mach B. (1988). N. Engl. J. Med., 318, 1295-1300.
7. Dingwall C and Laskey RA. (1991). Trends. Biochem. Sci., 16, 478-481.
8. Glimcher LH and Kara CJ. (1992). Annu. Rev. Immunol., 10, 13-49.
9. Griscelli C, Lisowska-Grospierre B and Mach B. (1989). Immunodef. Rev., 1, 135-153.
10. Kalderon D, Roberts BL, Richardson WD and Smith AE. (1984). Cell, 39, 499-509.
11. Kara CJ and Glimcher LH. (1991). Science, 252, 709-712.
12. Kara CJ and Glimcher LH. (1993). Immunogenetics, 37, 227-230.
13. Krief P, Boucheix C, Billard C, Mishal Z, Van Agthoven A, Fiers W and Azzarone B. (1987). Eur. J. Immunol., 17, 1021-1025.
14. Krief P, Augery-Bourget Y, Plaisance S, Merk MF, Assier E, Tanchou V, Billard M, Boucheix C, Jasmin C and Azzarone B. (1994). Oncogene, 9, 3449-3456.
15. Mach B, Steimle V and Reith W. (1994). Immunological Reviews, 138, 207-221.
16. Perrot JP, Krief P, Benoit P, Mirshahi M, Billard M, Rosenfeld C and Boucheix C. (1986). Scand. J. Immunol., 23, 623-629.
17. Riley JL, Westerheide SD, Price JA, Brown JA and Boss JM. (1995). Immunity, 2, 533-543.
18. Seed B and Aruffo A. (1987). Proc. Natl. Acad. Sci. USA, 84, 3305-3369.
19. Seed B. (1987). Nature, 329, 840-842.
20. Silacci P, Mottet A, Steimle V and Mach B. (1994). J. Exp. Med., 180, 1329-1336.
21. Steimle V, Otten LA, Zufferey M and Mach B. (1993). Cell, 75, 135-146.
22. Steimle V, Siegrist CA, Mottet A, Lisowska-Grospierre B and Mach B. (1994). Science, 265, 106-109.
23. Steimle V, Durand B, Barras E, Zufferey M, Hadam MR, Mach B and Reith W. (1995). Genes and development, 9, 1021-1032.
24. Ting JP-Y and Baldwin AS. (1993). Curr. Opin. Immunol., 5, 410-413.
25. Touraine JL, Marseglia GL and Betuel H. (1985). Exp. Hematol., 13 (suppl. 17), 86-87.
26. Zhou H and Glimcher LH. (1995). Immunity, 2, 545-553.